Elekta to become new issuer in the Swedish commercial paper market
STOCKHOLM – Elekta (EKTA-B.ST) has access to cost-effective and diverse financing. To further expand the range of available funding options, Elekta continuously reviews opportunities to utilize other sources of funding on the credit market. The company will therefore launch a Swedish commercial paper program in June 2024.
The commercial paper market is an established source of short-term financing for maturities of up to 12 months. The program is aimed primarily at increasing financing flexibility in short-term liquidity management. Danske Bank is the arranger and is also an issuing agent, together with SEB.
# # #
For further information, please contact:
Mattias Thorsson, Vice President, Head of Corporate Communications
Tel: +46 70 865 8012, e-mail: Mattias.Thorsson@elekta.com
Time zone: CET: Central European Time
Raven Canzeri, Global Director, Media Relations
Tel: +1 770-670-2524, e-mail: Raven.Canzeri@elekta.com
Time zone: ET: Eastern Time
About Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,500 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on “X”, formerly known as Twitter.